Page last updated: 2024-12-06

3,4,9,10-perylenetetracarboxylic dianhydride

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Cross-References

ID SourceID
PubMed CID67191
SCHEMBL ID36626
MeSH IDM0512007

Synonyms (58)

Synonym
c24h8o6
perylo[3,4-cd:9,10-c'd']dipyran-1,3,8,10-tetrone
3,4,9,10-perylenetetracarboxylic dianhydride
perylene-3,4,9,10-tetracarboxylic dianhydride
perylenetetracarboxylic acid dianhydride
perylo[3,10-c'd']dipyran-1,3,8,10-tetrone
3,10-perylenetetracarboxylic anhydride
perylenetetracarboxylic anhydride
perylene-3,9,10-tetracarboxylic 3,4:9,10-dianhydride
nsc79895
nsc-79895
perylene-3,9,10-tetracarboxylic dianhydride
128-69-8
3,9,10-perylenetetracarboxylic 3,4:9,10-dianhydride
3,9,10-perylenetetracarboxylic dianhydride
perylene-3,4,9,10-tetracarboxylic dianhydride, 97%
AC-10824
P0972
perylo(3,4-cd:9,10-c'd')dipyran-1,3,8,10-tetrone
AKOS003616705
nsc 79895
3,4,9,10-perylenetetracarboxylic 3,4:9,10-dianhydride
einecs 204-905-3
ec 204-905-3
perylene-3,4,9,10-tetracarboxylic 3,4:9,10-dianhydride
unii-nh27fw2pet
perylene-3,4:9,10-tetracarboxylic dianhydride
3,4:9,10-perylenetetracarboxylic anhydride
nh27fw2pet ,
7,18-dioxaheptacyclo[14.6.2.2^{2,5}.0^{3,12}.0^{4,9}.0^{13,23}.0^{20,24}]hexacosa-1(22),2(26),3,5(25),9,11,13,15,20,23-decaene-6,8,17,19-tetrone
FT-0631751
isochromeno[4',5',6':6,5,10]anthra[2,1,9-def]isochromene-1,3,8,10-tetrone
STL363235
anthra[2,1,9-def:6,5,10-d'e'f']diisochromene-1,3,8,10-tetraone
SCHEMBL36626
ptcda
DTXSID1059577
perylene-3,4,9, 10-tetracarboxylic dianhydride
W-108371
1,3,8,10-tetraoxaperylo[3,4-cd:9,10-c'd']dipyran
irgazin red bpt
mfcd00006916
GS-6719
perylene-3,4,9,10-tetracarboxylic dianhydride, 98%
3,4,9,10-perylenetetracarboxylicdianhydride;anthra[2,1,9-def:6,5,10-d'e'f']diisochromene-1,3,8,10-tetraone
SY050132
7,18-dioxaheptacyclo[14.6.2.22,5.03,12.04,9.013,23.020,24]hexacosa-1(23),2,4,9,11,13,15,20(24),21,25-decaene-6,8,17,19-tetrone
3,4,9,10-perylenetetracarboxylic dianhydride (purified by sublimation)
P2102
Q905520
YSSJ7325
CS-W011725
3,4,9,10-perylenetetracarboxylic acid dianhydride
perylenetetracarboxylic dianhydride
ci 71127
perylene-3,4:9,10-bis(dicarboxylic anhydride)
EN300-304990
7,18-dioxaheptacyclo[14.6.2.2^{2,5}.0^{3,12}.0^{4,9}.0^{13,23}.0^{20,24}]hexacosa-1(23),2,4,9,11,13,15,20(24),21,25-decaene-6,8,17,19-tetrone
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (30)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's11 (36.67)29.6817
2010's15 (50.00)24.3611
2020's4 (13.33)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 34.29

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index34.29 (24.57)
Research Supply Index3.43 (2.92)
Research Growth Index4.53 (4.65)
Search Engine Demand Index36.43 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (34.29)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other30 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]